Download PDF
Thromb Haemost 2017; 117(02): 277-285
DOI: 10.1160/TH16-06-0440
Coagulation and Fibrinolysis
Schattauer GmbH

The importance of genetic factors for the development of arthropathy: a longitudinal study of children and adolescents with haemophilia A

Edward D. Gomperts
1   Keck School of Medicine, University of Southern California and Children’s Hospital Los Angeles, Los Angeles, California, USA
,
John Schwarz
2   Department of Biostatistics, Rho, Inc., Chapel Hill, North Carolina, USA
,
Sharyne M. Donfield
2   Department of Biostatistics, Rho, Inc., Chapel Hill, North Carolina, USA
,
Alice E. Lail
2   Department of Biostatistics, Rho, Inc., Chapel Hill, North Carolina, USA
,
Jan Astermark
3   Lund University, Centre for Thrombosis and Haemostasis, Malmö, Sweden
,
W. Keith Hoots
4   Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA
,
Cheryl A. Winkler
5   Basic Research Laboratory, Centre for Cancer Research, National Cancer Institute, National Institutes of Health, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA
,
Erik Berntorp
3   Lund University, Centre for Thrombosis and Haemostasis, Malmö, Sweden
› Author Affiliations Financial support: This work is supported by the National Institutes of Health, National Institute of Child Health and Human Development, R01-HD-41224; by the Lund University, Centre for Thrombosis and Haemostasis, Skåne University Hospital Malmö/Lund, Malmö, Sweden; by an investigator-initiated grant from Baxter BioScience; and in part with federal funds from the NIH National Cancer Institute (NCI) under Contract No. HHSN261200800001E, and the Intramural Research Program of the NIH-NCI Center for Cancer Research.
Further Information

Publication History

Received:09 June 2016

Accepted after major revision:10 November 2016

Publication Date:
01 December 2017 (online)

    Permissions and Reprints

Summary

Haemophilia A is a congenital bleeding disorder characterised by recurrent haemorrhages into the major joints. Haemophilic arthropathy is a well-established outcome of recurrent joint bleeding; however, it is clear that multiple factors determine the extent and severity of its occurrence. We sought to identify genetic factors related to abnormalities in range of motion (ROM) in the knees, ankles and elbows in a cohort of children and adolescents with haemophilia A not treated primarily with regular prophylaxis. Using data from the Haemophilia Growth and Development Study, we examined associations between 13,342 genetic markers and ROM scores measured at six-month intervals for up to seven years. As a first step, ordered logistic regression models were fit for each joint separately. A subset of SNP markers showing significant effects (p<0.01) on the right and left sides for at least two joints were included in a full model fit using a multivariate generalised linear mixed model assuming an ordinal response. The models contained all ROM scores obtained at all visits. Twenty-five markers analysed in the full model showed either increased or decreased risk of ROM abnormalities at the p<0.001 level. Several genes identified at either the first or second stage of the analysis have been associated with arthritis in a variety of large studies. Our results support the likelihood that risk for haemophilic arthropathy is associated with genetic factors, the identification of which holds promise for further advancing the individualisation of treatment.

Keywords

Genetics - haemophilia - haemarthrosis - joint range of motion - arthritis
 

  • References

  • 1 Arnold WD, Hilgartner M. Hemophilic arthropathy. Current concepts of pathogenesis and management. J Bone Joint Surg Am 1977; 59: 287-305.
    CrossrefPubMedGoogle Scholar
  • 2 Madhok R, York J, Sturrock RD. Haemophilic arthritis. Ann Rheum Dis 1991; 50: 588-591.
    CrossrefPubMedGoogle Scholar
  • 3 Aledort L, Haschmeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. J Intern Med 1994; 236: 391-399.
    CrossrefPubMedGoogle Scholar
  • 4 Pollmann H, Richter H, Ringkamp H. et al. When are children diagnosed as having severe haemophilia and when do they start to bleed? A 10-year single-centre PUP study. Eur J Pediatr 1999; 158: S166-S170.
    CrossrefPubMedGoogle Scholar
  • 5 Soucie JM, Cianfrini C, Janco RL. et al. Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors. Blood 2004; 103: 2467-2473.
    CrossrefPubMedGoogle Scholar
  • 6 Nijdam A, Altisent C, Carcao MD. et al. Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades. Haematologica 2015; 100: e84.
    CrossrefPubMedGoogle Scholar
  • 7 Miners A, Sabin C, Tolley K. et al. Assessing health-related quality-of-life in individuals with haemophilia. Haemophilia 1999; 05: 378-385.
    CrossrefPubMedGoogle Scholar
  • 8 Mainardi CL, Levine PH, Werb Z. et al. Proliferative synovitis in hemophilia. Biochemical and morphologic observations. Arthritis Rheum 1978; 21: 137-144.
    CrossrefPubMedGoogle Scholar
  • 9 Valentino L. Blood-induced joint disease: the pathophysiology of hemophilic arthropathy. J Thromb Heamost 2010; 08: 1895-1902.
    PubMedGoogle Scholar
  • 10 Hakobyan N, Enockson C, Cole A. et al. Experimental haemophilic arthropathy in a mouse model of a massive haemarthrosis: gross, radiological and histological changes. Haemophilia 2008; 14: 804-809.
    CrossrefPubMedGoogle Scholar
  • 11 Forsyth A, Rivard GÉ, Valentino L. et al. Consequences of intra-articular bleeding in haemophilia: science to clinical practice and beyond. Haemophilia 2012; 18 (Suppl. 04) 112-119.
    CrossrefPubMedGoogle Scholar
  • 12 Roosendaal G, Vianen ME, Wenting MJ. et al. Iron deposits and catabolic properties of synovial tissue from patients with haemophilia. J Bone Joint Surg Br 1998; 80: 540-545.
    CrossrefPubMedGoogle Scholar
  • 13 Roosendaal G, Van Rinsum A, Vianen M. et al. Haemophilic arthropathy resembles degenerative rather than inflammatory joint disease. Histopathology 1999; 34: 144-153.
    CrossrefPubMedGoogle Scholar
  • 14 Decker J, Malone D, Haraoui B. et al. Rheumatoid arthritis: evolving concepts of pathogenesis and treatment. Ann Intern Med 1984; 101: 810-824.
    CrossrefPubMedGoogle Scholar
  • 15 Hooiveld MJ, Roosendaal G, Van Den Berg H. et al. Haemoglobin-derived iron-dependent hydroxyl radical formation in blood-induced joint damage: an in vitro study. Rheumatology 2003; 42: 784-790.
    CrossrefPubMedGoogle Scholar
  • 16 Wen F-Q, Jabbar AA, Chen Y-X. et al. C-myc proto-oncogene expression in hemophilic synovitis: in vitro studies of the effects of iron and ceramide. Blood 2002; 100: 912-916.
    CrossrefPubMedGoogle Scholar
  • 17 Hooiveld M, Roosendaal G, Wenting M. et al. Short-term exposure of cartilage to blood results in chondrocyte apoptosis. Am J Pathol 2003; 162: 943-951.
    CrossrefPubMedGoogle Scholar
  • 18 Manco-Johnson MJ, Abshire TC, Shapiro AD. et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-544.
    CrossrefPubMedGoogle Scholar
  • 19 Ragni M, Fogarty P, Josephson N. et al. Survey of current prophylaxis practices and bleeding characteristics of children with severe haemophilia A in US haemophilia treatment centres. Haemophilia 2012; 18: 63-68.
    CrossrefPubMedGoogle Scholar
  • 20 Nilsson I, Berntorp E, Löfqvist T. et al. Twenty-five years’ experience of prophylactic treatment in severe haemophilia A and B. J Intern Med 1992; 232: 25-32.
    CrossrefPubMedGoogle Scholar
  • 21 Carcao MD, van den Berg HM, Ljung R. et al. Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A. Blood 2013; 121: 3946-3952.
    CrossrefPubMedGoogle Scholar
  • 22 Ahlberg A. Indicence, treatment and prophylaxis of arthropathy and other musculoskeletal manifestations of haemophilia A and B. Acta Orthop Scand 1965; 05: 20-39.
    PubMedGoogle Scholar
  • 23 Astermark J, Donfield S, Gomperts E. et al. The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort. Blood 2013; 121: 1446-1454.
    CrossrefPubMedGoogle Scholar
  • 24 Hilgartner MW, Donfield SM, Willoughby A. et al. Hemophilia Growth and Development Study: Design, Methods Entry Data. J Pediatr Hematol Oncol 1993; 15: 208-218.
    CrossrefPubMedGoogle Scholar
  • 25 Lakich D, Kazazian H, Antonarakis S. et al. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet 1993; 05: 236-241.
    CrossrefPubMedGoogle Scholar
  • 26 Oldenburg J. Mutation profiling in haemophilia A. Thromb Haemost 2001; 85: 577-579.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Price AL, Patterson NJ, Plenge RM. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904-909.
    CrossrefPubMedGoogle Scholar
  • 28 Eleftherohorinou H, Hoggart CJ, Wright VJ. et al. Pathway-driven gene stability selection of two rheumatoid arthritis GWAS identifies and validates new susceptibility genes in receptor mediated signalling pathways. Hum Mol Gen 2011; 20: 3494-3506.
    CrossrefPubMedGoogle Scholar
  • 29 Hüffmeier U, Uebe S, Ekici AB. et al. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nature Genet 2010; 42: 996-999.
    CrossrefPubMedGoogle Scholar
  • 30 Feng B, Sun L, Soltani-Arabshahi R. et al. Multiple loci within the major histocompatibility complex confer risk of psoriasis. PLoS Genet 2009; 05: 0e1000606.
    CrossrefPubMedGoogle Scholar
  • 31 Liu Y, Helms C, Liao W. et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 2008; 04: e1000041.
    CrossrefPubMedGoogle Scholar
  • 32 Gregersen P, Amos C, Lee A. et al. REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet 2009; 41: 820-823.
    CrossrefPubMedGoogle Scholar
  • 33 Ellinghaus E, Stuart PE, Ellinghaus D. et al. Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL. J Invest Dermatol 2012; 132: 1133-1140.
    CrossrefPubMedGoogle Scholar
  • 34 Wang J, Bansal A, Martin M. et al. Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis. Pharmacogenomics 2013; 13: 235-241.
    CrossrefPubMedGoogle Scholar
  • 35 Stahl E, Raychaudhuri S, Remmers E. et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nature Genet 2010; 42: 508-514.
    CrossrefPubMedGoogle Scholar
  • 36 Sheth T, Pitchumoni C, Das K. Musculoskeletal Manifestations in Inflammatory Bowel Disease: A Revisit in Search of Immunopathophysiological Mechanisms. J Clin Gastroenterol 2014; 48: 308-317.
    CrossrefPubMedGoogle Scholar
  • 37 Zhang M, Wang J. Epigenetics and Osteoarthritis. Genes Dis 2015;. Epub ahead of print.
    PubMedGoogle Scholar
  • 38 Fransen M, Simic M, Harmer A. Determinants of MSK health and disability: Lifestyle determinants of symptomatic osteoarthritis. Best Pract Res Clin Rheumatol 2014; 28: 435-460.
    CrossrefPubMedGoogle Scholar
  • 39 Roosendaal G, Jansen NW, Schutgens R. et al. Haemophilic arthropathy: the importance of the earliest haemarthroses and consequences for treatment. Haemophilia 2008; 14 (Suppl. 06) 4-10.
    CrossrefPubMedGoogle Scholar
  • 40 Roosendaal G, Lafeber FP. Pathogenesis of haemophilic arthropathy. Haemophilia 2006; 12 (Suppl. 03) 117-121.
    CrossrefPubMedGoogle Scholar
  • 41 Astermark J, Petrini P, Tengborn L. et al. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized. Brit J Haematol 1999; 105: 1109-1113.
    CrossrefPubMedGoogle Scholar
  • 42 Fischer K, Carlsson K, Petrini P. et al. Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s. Blood 2013; 122: 1129-1136.
    CrossrefPubMedGoogle Scholar